The Lancet Neurology in conversation with

Eva Feldman on advances in understanding ALS

April 13, 2022 The Lancet Neurology
The Lancet Neurology in conversation with
Eva Feldman on advances in understanding ALS
Show Notes

Eva Feldman (University of Michigan, Ann Arbor, USA) discusses the latest advances in the genetics, risk factors, pathophysiology, therapeutic development, and the diagnosis and prognosis of amyotrophic lateral sclerosis; the Series is published in the May issue of The Lancet Neurology.

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv